phrykt

Idexx Laboratories (IDXX) net income: $1.1B

Idexx Laboratories reported a net income of $1.1B for the year ended Dec 31, 2025, up 19.3% from $888M a year earlier.

From Idexx Laboratories's filings with the SEC · Read the filing · IDXX stock page

Idexx Laboratories net income by year

$745M2021$679M2022$845M2023$888M2024$1.1B2025

#361 of 3,748 US companies by net income · See the full ranking

Year endedNet incomeChange
Dec 31, 2025$1.1B+19%
Dec 31, 2024$888M+5%
Dec 31, 2023$845M+24%
Dec 31, 2022$679M-9%
Dec 31, 2021$745M–

Net income of similar companies

Companies in the same industry as Idexx Laboratories, by SEC industry code, with the closest net income. Each name opens the same page for that company.

CompanyNet income, latest yearYear ended
TEVA Pharmaceutical Industries$1.4BDec 31, 2025
United Therapeutics$1.3BDec 31, 2025
Biogen$1.3BDec 31, 2025
Idexx Laboratories$1.1BDec 31, 2025
Exelixis$783MJan 2, 2026
Royalty Pharma$771MDec 31, 2025
PTC Therapeutics$683MDec 31, 2025

Questions and answers

What is Idexx Laboratories's net income?

Idexx Laboratories reported a net income of $1.1B for the year ended Dec 31, 2025, up 19.3% from $888M a year earlier.

Numbers as reported in Idexx Laboratories's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology